Legend Biotech
LEGN
LEGN
158 hedge funds and large institutions have $3.28B invested in Legend Biotech in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 80 increasing their positions, 46 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $3.18B → $3.28B (+$104M)
6% less funds holding
Funds holding: 168 → 158 (-10)
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
Holders
158
Holding in Top 10
7
Calls
$18.5M
Puts
$7.63M
Top Buyers
| 1 | +$60.4M | |
| 2 | +$44.1M | |
| 3 | +$24.1M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$23.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$22.8M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$19.1M | |
| 3 | -$16.5M | |
| 4 |
D.E. Shaw & Co
New York
|
-$13.6M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$13.6M |